跳至主要内容
临床试验/NCT03744546
NCT03744546No Longer Available不适用

Expanded Access to ABBV-8E12

AbbVie0 个研究点开始时间: 2018年11月16日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
No Longer Available
发起方

研究概览

简要总结

This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to ABBV-8E12 prior to approval by the local regulatory agency. Availability will depend on territory eligibility. Participating sites will be added as they apply for and are approved for the EAP. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.

研究设计

研究类型
Expanded Access

入排标准

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
AbbVie
申办方类型
Industry
责任方
Sponsor

相似试验